Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant;Utilización de procalcitonina y proteína C reactiva como marcadores de infección en la neutropenia febril de pacientes sometidos a trasplante de progenitores hematopoyéticos

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 32, Issue 7, 2014, Pages 418-423

  Sánchez Yepes, Marina ^a   Aznar Oroval, Eduardo ^a   Lorente Alegre, Pablo ^b   García Lozano, Tomás ^a   Picón Roig, Isabel ^b   Pérez Ballestero, Pilar ^a   Ortiz Muñoz, Blanca ^a  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

C reactive protein; Febrile neutropenia; Procalcitonin

Indexed keywords

ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DISEASE MARKER; FEBRILE NEUTROPENIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IATROGENIC DISEASE; BACTEREMIA; BACTERIAL INFECTION; CHEMOTHERAPY; FEVER; SENSITIVITY AND SPECIFICITY; ADULT; AGED; BLOOD; COMPLICATION; FEMALE; MALE; MIDDLE AGED; NEUTROPENIA; PREDICTIVE VALUE;

ADULT; AGED; BIOMARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; FEVER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS;

EID: 84905510806     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2013.09.003     Document Type: Article

References (32)

1. G.P. Bodey, M. Buckley, Y.S. Sathe, and E.J. Freireich Quantitative relationships between circulating leucocytes and infection in patients with acute leukemia Ann Intern Med 64 1966 328 340
2. D.C. Dale, D. Guerry, J.R. Wewerka, M.J. Bull, and M.J. Chusid Chronic neutropenia Medicine (Baltimore) 58 1979 128 144
3. N. Schmidt, J. Palma, A. King, and M.E. Santolaya Proteína C reactiva y procalcitonina como marcadores de infección bacteriana en niños con neutropenia febril posterior a trasplante alogénico de progenitores hematopoyéticos Rev Med Chile 135 2007 982 989
4. D.E. Adelberg, and M.R. Bishop Emergencies related to cancer chemotherapy and hematopoietic stem cell transplantation Emerg Med Clin North Am 27 2009 311 331
5. W.T. Hugues, D. Armstrong, G.P. Bodey, E.J. Boww, A.E. Brown, and T. Calandra et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer Clin Infect Dis 34 2002 730 751
6. P.A. Pizzo Management of fever in patients with cancer and treatment induced neutropenia N Engl J Med 328 1993 1323 1332
7. B.A. Rasool Hassan, Z.B. Yusoff, and S.B. Othman Fever/clinical signs and association with neutropenia in solid cancer patients: Bacterial infection as de main cause Asian Pac J Cancer Prev 11 2010 1273 1277
8. P. Torrabadella de Reynoso, and H. Pérez-Moltó La proteína C reactiva en los tiempos de la medicina molecular Med Clin 125 2005 775 777
9. M. Meisner Procalcitonin (PCT). A new, innovative infection parameter. Biochemical and clinical aspects BRAHMS Diagnostica GmbH 1996
10. P. Dandona, D. Nix, M.F. Wilson, A. Aljada, J. Love, and M. Assicot et al. Procalcitonin increase after endotoxin infection in normal subjects J Clin Endocrinol Metab 93 1994 54 58
11. Comisión Magnitudes Biológicas relacionadas con la Urgencia Médica. Procalcitonina: utilidad y recomendaciones para su medición en el laboratorio. SEQC 2011. Documento P. Fase 3. Versión 3.
12. M. Svaldi, J. Hirber, A.I. Lanthaler, O. Mayr, S. Faes, and E. Peer et al. Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients Br J Haematol 115 2000 53 57
13. G. Fleischhack, I. Kambeck, D. Cipic, C. Hasan, and U. Bode Procalcitonin in paediatric cancer patients: Its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II Br J Haematol 111 2000 102 1093
14. A. Engel, G. Steinbach, P. Kern, and W.V. Kern Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: Comparison with interleukin 8 Scand J Infect Dis 31 1999 9 185
15. L. Bernard, F. Ferriere, P. Casassus, F. Malas, S. Leveque, and L. Guillevin et al. Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults Clin Infect Dis 27 1998 5 914
16. C. Ferrà, A. Lacoma, O. García, P. Marcos, J. Domínguez, and J.M. Ribera Relación entre los valores séricos de procalcitonina y las complicaciones y supervivencia de pacientes con hemopatías malignas ingresados en una Unidad de Vigilancia Intensiva Med Clin 138 2012 385 388
17. E. Loza Fernández de Bobadilla, A. Planes Reig, and M. Rodriguez Creixems Hemocultivos E. Cercenado, R. Canton, Procedimientos en Microbiología Clínica. Recomendaciones de la Sociedad Española de EnfermedadesInfecciosas y Microbiología Clínica 2003 [consultado 26 Mar 2009] Disponible en: http://www.seimc.org/protocolos/ microbiología
18. M. Ortega, M. Rovira, X. Filella, J.A. Martinez, M. Almela, and J. Puig et al. Prospective evaluation of procalcitonin in adults with non-neutropenic fever after allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant 37 2006 499 502
19. D.Y. Kim, Y.S. Lee, S. Ahn, Y.H. Chun, and K.S. Lim The usefulness of procalcitonin and C-reactive protein as early diagnostic markers of bacteriemia in cancer patients with febrile neutropenia Cancer Res Treat 43 2011 80 176
20. M. Von Lilienfeld-Toal, M.P. Dietrich, A. Glasmacher, L. Lehmann, P. Breig, and C. Hahn et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein Eur J Clin Microbiol Infect Dis 23 2004 44 539
21. J.O. Robinson, F. Lamoth, F. Bally, M. Knaup, T. Calandra, and O. Marchetti Monitoring procalcitonin in febrile neutropenia: what is its utility for initial diagnosis of infection and reassessment in persistent fever? PLoS One 6 2011 e18886
22. M.T. Sandri, R. Passerini, M.E. Leon, F.A. Peccatori, L. Zorzino, and M. Salvatici et al. Procalcitonin as a useful marker of infection in hemato-oncological patients with fever Anticancer Res 28 2008 6 3061
23. L. Hambach, M. Eder, E. Dammann, A. Schrauder, K.W. Sykora, and C. Dieterich et al. Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation Haematologica 87 2002 51 643
24. E. Aznar-Oroval, M. Sánchez-Yepes, P. Lorente-Alegre, M.C. Sanjuan-Gadea, B. Ortiz-Muñoz, and P. Pérez-Ballestero et al. Valor diagnóstico de la procalcitonina, la interleucina 8, la interleucina 6 y la proteína C reactiva en la detección de bacteriemia y fungemia en pacientes con cáncer Enferm Infecc Microbiol Clin 28 2010 7 273
25. A.J. Reitman, R.M. Pisk, J.V. Gates 3rd, and J.D. Ozeran Serial procalcitonin levels to detect bacteremia in febrile neutropenia Clin Pediatr 51 2012 1175 1183
26. E. Ruokonen, T. Nousiainen, K. Pulkki, and J. Takala Procalcitonin concentrations in patients with neutropenic fever Eur J Clin Microbiol Infect Dis 18 1999 5 283
27. H. Giamarellou, E.J. Giamarellos-Bourboulis, P. Repoussis, L. Galani, N. Anagnostopoulos, and P. Grecka et al. Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study Clin Microbiol Infect 10 2004 33 628
28. P. Tudela, C. Prat, A. Lacoma, and J.M. Mòdol Biomarcadores y sospecha de infección en los servicios de urgencias Med Clin (Barc) 139 2012 7 33
29. S. Riedel, J.H. Melendez, A.T. An, J.E. Rosenbaum, and J.M. Zenilman Procalcitonin as a marker for the detection of bacteriemia and sepsis in the emergency department Am J Clin Pathol 135 2011 9 182
30. M. Vänskä, I. Koivula, E. Jantunen, S. Hämälä inen, A.K. Purhonen, and K. Pulkki et al. IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients Cytokine 60 2012 92 787
31. M. Sauer, K. Tiede, D. Fuchs, B. Gruhn, D. Berger, and F. Zintl Procalcitonin C-reactive protein, and endotoxin after bone marrow transplantation: identification of children at high risk of morbidity and mortality from sepsis Bone Marrow Transplant 31 2003 42 1137
32. A. Lacoma, C. Prat, and V. Ausina Relevancia de los marcadores de inflamación en el diagnóstico, pronóstico y nuevas formas de tratamiento de las enfermedades infecciosas Enferm Infecc Microbiol Clin 28 2010 5 263